Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF

25-Hydroxy-vitamin D3 level is a predictor to insulin resistance in patients with hepatitis C virus-induced liver cirrhosis

The Egyptian Journal of Internal Medicine volume 25, pages 63–69 (2013)Cite this article

Abstract

Background

There is an established relationship between liver disease and hepatogenous diabetes mellitus, and a growing evidence for the role of vitamin D deficiency in the pathogenesis of type 1 and type 2 diabetes mellitus. However, data on the impact of vitamin D serum level on insulin resistance among liver cirrhosis patients are lacking.

Objectives of the study

The primary objective of the current study was to investigate the relationship between vitamin D status and insulin resistance among hepatitis C virus (HCV)-induced liver cirrhosis patients using a homeostasis model for assessment of insulin resistance (HOMA-IR). The secondary objectives were to assess the association between deterioration of liver function on the one hand and insulin resistance and vitamin D deficiency on the other.

Participants and methods

Fifty patients with biopsy-proved HCV-induced liver cirrhosis were enrolled in this cross-sectional study. Routine clinical, laboratory, and imaging workout was performed to assess the degree of liver decompensation using the model of end-stage liver disease (MELD) score and the Child–Turcotte–Pugh Score (CTPS). Serum level of 25-hydroxy-vitamin D3 [25(OH)D3] was estimated. Fasting plasma glucose and fasting insulin were also measured to calculate HOMA-IR as an indicator of insulin resistance. Patients were subclassified according to serum 25(OH)D3 levels into tertiles, according to the MELD score into three groups, and according to CTPS into Child A, B, and C.

Results

A significant inverse correlation was found between serum 25(OH)D3 level and insulin resistance as assessed by HOMA-IR, whether using one-by-one correlation (r = −0.976, P =0.000) or using 25(OH)D3 tertiles’ correlation (r = −0.830, P =0.000). Linear multiple regression analysis determined low serum 25(OH)D3 level as an independent predictor for increase in HOMA-IR among HCV-induced liver cirrhosis patients. No significant association was identified between low serum 25(OH)D3 level and the severity of liver dysfunction as assessed by the MELD score or CTPS.

Conclusion

The present study showed that low serum 25(OH)D3 level was an independent predictor for insulin resistance among patients with HCV-induced liver cirrhosis.

References

  1. García Compean D, Jaquez Quintana JO, Maldonado Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol 2009; 8:13–20.

    Article  PubMed  Google Scholar 

  2. Garcia Compean D, Jacquez Quintana JO, Gonzalez Gonzalez JA Maldonado Garza H. Liver cirrhosis and diabetes: risk factors, pathophy-siology, clinical implications and management. World J Gastroenterol 2009; 15:280–288.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Petrides AS, Groop LC, Riely CA, DeFronzo RA. Effect of physiologic hyperinsulinemia on glucose and lipid metabolism in cirrhosis. J Clin Invest 1991; 88:561–570.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sakata M, Kawahara A, Kawaguchi T, Akiba J, Taira T, Taniguchi E, et al. Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens. J Gastroenterol 2012; 48:277–285.

    Article  CAS  PubMed  Google Scholar 

  5. Perseghin G, Mazzaferro V, Sereni LP, Regalia E, Benedini S, Bazzigaluppi E, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatology 2000; 31:694–703.

    Article  CAS  PubMed  Google Scholar 

  6. Putz Bankuti C, Pilz S, Stojakovic T, Scharnagl H, Pieber TR, Trauner M, et al. Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease. Liver Int 2012; 32:845–851.

    Article  CAS  PubMed  Google Scholar 

  7. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005; 48:1247–1257.

    Article  CAS  PubMed  Google Scholar 

  8. Lee BK, Park S, Kim Y. Age- and gender-specific associations between low serum 25-hydroxyvitamin D level and type 2 diabetes in the Korean general population: analysis of 2008-2009 Korean National Health and Nutrition Examination Survey Data. Asia Pac J Clin Nutr 2012; 21:536–546.

    CAS  PubMed  Google Scholar 

  9. Gagnon C, Lu ZX, Magliano DJ, Dunstan DW, Shaw JE, Zimmet PZ, et al. Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 2012; 97:1953–1961.

    Article  CAS  PubMed  Google Scholar 

  10. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 2006; 12:1049–1061.

    Article  PubMed  Google Scholar 

  11. Child CG. The hepatic circulation and portal hypertention. Philadelphia: W.B. Saunders; 1954.

    Google Scholar 

  12. Pugh RNH, Murray Lyon IM, Dawson JL. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60:646–649.

    Article  CAS  PubMed  Google Scholar 

  13. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412–419.

    Article  CAS  PubMed  Google Scholar 

  14. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22:158–161.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Delams HG. Biochemical analysis of human and animal serum for monoclonal antibodies using ELISA. Biochemistry 1986; 14:214–231.

    Google Scholar 

  16. Wielders JPM, Wijnberg FA. Preanalytical stability of 25(OH)-vitamin D3 in human blood or serum at room temperature: solid as a rock. Clin Chem 2009; 55:1584–1585.

    Article  CAS  PubMed  Google Scholar 

  17. James WPT. 22nd Marabou Symposium: the changing faces of vitamin D. Nutr Rev 2008; 66:286–290.

    Article  PubMed  Google Scholar 

  18. Rahman SA, Chee WSS, Yassin Z, Chan SP Vitamin D status among postmenopausal Malaysian women. Asia Pac J Clin Nutr 2004; 13:255–260.

    CAS  PubMed  Google Scholar 

  19. Palomer X, Gonzalez Clemente JM, Blanco Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab 2008; 10:185–197.

    Article  CAS  PubMed  Google Scholar 

  20. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and b-cell dysfunction. Am J Clin Nutr 2004; 79:820–825.

    Article  CAS  PubMed  Google Scholar 

  21. Al Daghri NM, Alkharfy KM, Al Othman A, El Kholie E, Moharram O, Alokail MS, et al. Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovasc Diabetol 2012; 11:85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Holick MF. Medical progress: vitamin D deficiency. N Engl J Med 2007; 357:266–281.

    Article  CAS  PubMed  Google Scholar 

  23. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89:555–572.

    Article  CAS  Google Scholar 

  24. Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007; 30:734–743.

    Article  CAS  PubMed  Google Scholar 

  25. Holstein A, Hinze S,Thießen E, Plaschke A, Egberts EH. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002; 1 7:677–681.

    Article  Google Scholar 

  26. Nishida T, Tsuji S, Tsujii M, Arimitsu S, Haruna Y, Imano E, et al. Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol 2006; 101:70–75.

    Article  PubMed  Google Scholar 

  27. Kawaguchi T, Yoshida T, Harada M, Hisamoto T, Nagao Y, Ide T, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004; 165:1499–1508.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev 2009; 22:82–92.

    Article  CAS  PubMed  Google Scholar 

  29. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 2008; 7:1–5.

    Article  CAS  Google Scholar 

  30. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, Martin LW, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94:209–217.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kishta SA, Abd Alhade AA, Hamam O, Raoof EA, Abeya S. Prognostic value of TNF a mRNA and VEGF mRNA expression in patients with chronic hepatitis C genotype-4, with and without cirrhosis and hepatocellular carcinoma to predict disease outcome. J Egypt Soc Parasitol 2010; 40:515–530.

    CAS  PubMed  Google Scholar 

  32. Roden M. Mechanisms of disease: hepatic steatosis in type 2 diabetes – pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2006; 2:335–348.

    Article  CAS  PubMed  Google Scholar 

  33. Baker RG, Hayden MS, Ghosh S. NF-kB, inflammation and metabolic disease. Cell Metab 2011; 13:11–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Cohen Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkB activity by increasing lкBα levels. Nephrol Dial Transpl 2006; 21:889–897.

    Article  CAS  Google Scholar 

  35. Haussler MR, Haussler CA, Bartik L, Whitfield GK, Hsieh JC, Slater S, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev 2008; 66 (Suppl 2): S98–S112.

    Article  PubMed  Google Scholar 

  36. Billaudel BJ, Bourlon PM, Sutter BC, Faure Dussert AG. Regulatory effect of 1,25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats. J Endocrinol Invest 1995; 18:673–682.

    Article  CAS  PubMed  Google Scholar 

  37. Bourlon PM, Faure Dussert A, Billaudel B. Modulatory role of 1,25 dihydroxyvitamin D3 on pancreatic islet insulin release via the cyclic AMP pathway in the rat. Br J Pharmacol 1997; 121:751 – 758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bourlon PM, Billaudel B, Faure Dussert A. Influence of vitamin D3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 1999; 160:87–95.

    Article  CAS  PubMed  Google Scholar 

  39. Li J, Byrne ME, Chang E, Jiang Y, Donkin SS, Buhman KK, et al. 1α,25-Dihydroxyvitamin D hydroxylase in adipocytes. J Steroid Biochem Mol Biol 2008; 112 (1–3):122–126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Bland R, Markovic D, Hills CE, Hughes SV, Chan SLF, Squires PE, et al. Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J Steroid Biochem Mol Biol 2004; 89–90:121–125.

    Article  CAS  PubMed  Google Scholar 

  41. Maestro B, Dávila N, Carranza MC, Calle C. Identification of a Vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 2003; 84 (2–3): 223–230.

    Article  CAS  PubMed  Google Scholar 

  42. Maestro B, Campión J, Dávila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocrine J 2000; 47:383–391.

    Article  CAS  Google Scholar 

  43. Allali F, El Aichaoui S, Khazani H, Benyahia B, Saoud B, El Kabbaj S, et al. High prevalence of hypovitaminosis D in Morocco: relationship to lifestyle, physical performance, bone markers and bone mineral density. Semin Arthritis Rheum 2009; 38:444–451.

    Article  CAS  PubMed  Google Scholar 

  44. Meddeb N, Sahli H, Chahed M, Abdelmoula J, Feki M, Salah H, et al. Vitamin D deficiency in Tunisia. Osteoporos Int 2005; 16:180–183.

    Article  CAS  PubMed  Google Scholar 

  45. Baroncelli GI, Bereket A, El Kholy M, Audì L, Cesur Y, Ozkan B, et al. Rickets in the Middle East: role of environment and genetic predisposition. J Clin Endocrinol Metab 2008; 93:1743–1750.

    Article  CAS  PubMed  Google Scholar 

  46. Zúñiga S, Firrincieli D, Housset C, Chignard N. Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 2011; 35:295015–302.

    Article  CAS  Google Scholar 

  47. Bitetto D, Fabris C, Falleti E, Fornasiere E, Fumolo E, Fontanini E, et al. Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int 2010; 30:417–422.

    Article  CAS  PubMed  Google Scholar 

  48. Petta S, Cammà C, Scazzone C, Tripodo C, Marco VD, Bono A, et al. Low vitamin d serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology 2010; 51:1158–1167.

    Article  CAS  PubMed  Google Scholar 

  49. Malham M, Jørgensen SP, Ott P, Agnholt J, Vilstrup H, Borre M, et al. Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol 2011; 17:922–925.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Schaalan MF, Mohamed WA, Amin HH. Vitamin D deficiency: correlation to interleukin-17, interleukin-23 and PIIINP in hepatitis C virus genotype 4. World J Gastroenterol 2012; 18:3738–3744.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Gundling F, Seidl H, Pehl C, Schmidt T, Schepp W. How close do gastro-enterologists follow specific guidelines for nutrition recommendations in liver cirrhosis? A survey of current practice. Eur J Gastroenterol Hepatol 2009; 21:756–761.

    Article  PubMed  Google Scholar 

  52. Plauth M, Schütz ET. Cachexia in liver cirrhosis. Int J Cardiol 2002; 85: 83–87.

    Article  PubMed  Google Scholar 

  53. Dibble JB, Sheridan P, Hampshire R, Hardy GJ, Losowsky MS. Osteomalacia, vitamin D deficiency and cholestasis in chronic liver disease. Q J Med 1982; 51:89–103.

    CAS  PubMed  Google Scholar 

  54. Barakat M, Mostafa M, Mahran Z, Soliman AG. Portal hypertensive duode-nopathy: clinical, endoscopic and histopathologic profiles. Am J Gastroenterol 2007; 102:2793–2802.

    Article  PubMed  Google Scholar 

  55. Del Vecchio Blanco C, Gentile S, Marmo R, Carbone L, Coltorti M. Alterations of glucose metabolism in chronic liver disease. Diabetes Res Clin Pract 1990; 8:29–36.

    Article  PubMed  Google Scholar 

  56. Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A, Pisi E. Prognostic significance of diabetes in patients with cirrhosis. Hepatology 1994; 20 (11): 119–125.

    CAS  PubMed  Google Scholar 

  57. Karaman A, Bayram F, Gundogan K, Ozsan M, Karaman H, Kelestimur F. Prevalence of diabetes mellitus and glucose metabolism disorders in the first degree relatives of type 2 diabetic patients. Bratisl Lek Listy 2012; 113:361–367.

    CAS  PubMed  Google Scholar 

  58. Romero Gómez M, Del Mar Viloria M, Andrade RJ, Salmerón J, Diago M, Fernández Rodríguez CM, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 2005; 128:636–641.

    Article  CAS  PubMed  Google Scholar 

  59. Kim MG, Choi WC. Differential diagnosis of diabetes mellitus caused by liver cirrhosis and other type 2 diabetes mellitus. Korean J Hepatol 2006; 12:524–529.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Department, Faculty of Medicine, Cairo University, Cairo, 12556, Egypt

    Abir Zakaria (MD), Nagwa Ramadan & Naglaa El-Sayed

  2. Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt

    Amr Zahra

Authors
  1. Abir Zakaria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nagwa Ramadan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naglaa El-Sayed
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Amr Zahra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abir Zakaria.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zakaria, A., Ramadan, N., El-Sayed, N. et al. 25-Hydroxy-vitamin D3 level is a predictor to insulin resistance in patients with hepatitis C virus-induced liver cirrhosis. Egypt J Intern Med 25, 63–69 (2013). https://doi.org/10.7123/01.EJIM.0000428088.55438.42

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.7123/01.EJIM.0000428088.55438.42

Keywords